Angela Zhou is an Information Scientist at CAS. She earned her Ph.D. in Molecular Pharmacology and toxicology from University of Southern California. She was further trained as a cell biologist at Johns Hopkins School of Medicine and worked in the area of cancer biology at Harvard Medical School. She was a faculty member at Missouri State University and Denison University prior to joining CAS.
Since the outbreak of COVID-19, caused by SARS-CoV-2 virus, scientists have been racing to understand it. Extensive research has been devoted to identifying viable genes and proteins as targets for therapeutic agents. One particular protein that has drawn considerable attention is the human cell’s viral receptor, angiotensin-converting enzyme 2 (ACE2).